Granite Investment Partners’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.5K Buy
+14,831
New +$45.5K ﹤0.01% 252

Other funds holding STLN

Granite Investment Partners's STLN Position: Q1 2026 in Review

Granite Investment Partners opened a new position in Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2026: 14,831 shares worth $45.5K. The stake represents ﹤0.01% of the portfolio and ranks #252 among its holdings.

115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Granite Investment Partners held 14,831 shares of Starling Oncology Institute, Inc. Common Stock worth $45.5K as of Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock was a new Granite Investment Partners position in Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Granite Investment Partners's portfolio in Q1 2026, its #252 holding.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.